학술논문

IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients
Document Type
Journal
Source
BREAST CANCER RESEARCH AND TREATMENT; SEP 2017, 165 2, p343-p353, 11p.
Subject
Language
English
ISSN
15737217